What percent of REPL is sold short?

55.6% of Replimune (REPL) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is REPL a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for Replimune (REPL).

REPL Short Volume Hit 55.6%

$13.07

-0.38 (-2.83%)

Weekly Expected Move ±6.5%

$11 $12 $13 $14 $15

NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $1.1B mcap · 79M float · 5.95% daily turnover · Short 56% of daily vol

Short Volume Summary

2026-10-01

59.1%

Short Ratio

of total volume

55.8%

20-Day Avg

53.7%

50-Day Avg

▼ Falling

5-Day Trend

0.5M

Short Volume

0.8M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	450,916	757,623	59.5%
NYSE	34,537	62,833	55.0%
BATS	3,034	5,546	54.7%

REPL Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet